The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury
Open accessAbstract
Drug-induced liver injury (DILI) is the most common adverse event causing drug nonapprovals and drug withdrawals. Using drugs as test agents and measuring a panel of cellular phenotypes that are directly linked to key mechanisms of hepatotoxicity, we have developed an in vitro testing strategy that is predictive of many clinical outcomes of DILI. Mitochondrial damage, oxidative stress, and intracellular glutathione, all measured by high content cellular imaging in primary human hepatocyte cultures, are the three most important features contributing to the hepatotoxicity prediction. When applied to over 300 drugs and chemicals including many that caused rare and idiosyncratic liver toxicity in humans, our testing strategy has a true-positive rate of 50-60% and an exceptionally low false-positive rate of 0-5%. These in vitro predictions can augment the performance of the combined traditional preclinical animal tests by identifying idiosyncratic human hepatotoxicants such as nimesulide, telithromycin, nefazodone, troglitazone, tetracycline, sulindac, zileuton, labetalol, diclofenac, chlorzoxazone, dantrolene, and many others. Our findings provide insight to key DILI mechanisms, and suggest a new approach in hepatotoxicity testing of pharmaceuticals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
(2012) · Encyclopedia of the Sciences of Learning · doi:10.1007/978-1-4419-1428-6_5195 · Cited by 19,370
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 1×
“The combined preclinical animal testing from rodents, dogs, and monkeys can only identify about half of hepatotoxic drugs in humans (Olson et al., 2000).”
BackgroundLee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
The use of receiver operating characteristic curves in biomedical informatics
Lasko, T. A., Bhagwat, J. G., Zou, K. H., & Ohno-Machado, L. (2005) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2005.02.008 · Cited by 823
Navarro, V. J., & Senior, J. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052270 · Cited by 811
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
O’Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0091-3 · Cited by 609
Adverse drug reactions in elderly patients
Routledge, P. A., O'Mahony, M. S., & Woodhouse, K. W. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01875.x · Cited by 476
Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., Corvi, R., Darroudi, F., Elhajouji, A., Glatt, H., Hastwell, P., Hayashi, M., et al. (2007) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.11.008 · Cited by 445
Why Drugs Fail - A Study on Side Effects in New Chemical Entities
Schuster, D., Laggner, C., & Langer, T. (2005) · Current Pharmaceutical Design · doi:10.2174/138161205774414510 · Cited by 417 · cited 2×
“It is the leading cause in acute liver failures that necessitate organ transplants, safety recalls from the world-wide pharmaceutical market, nonapprovable decisions regarding new drug applications (NDAs), and internal drug development failures among all major pharmaceutical companies (Giacomini et al., 2007; Holt and…”
BackgroundBerson, A., De Beco, V., Lettéron, P., Robin, M. A., Moreau, C., Kahwaji, J. E., Verthier, N., Feldmann, G., Fromenty, B., & Pessayre, D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70590-6 · Cited by 405
Hy's law: predicting serious hepatotoxicity
Temple, R. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1211 · Cited by 352
Mecanismos de lesión hepatocelular
Muntané, J., González, R., Ranchal, I., Collado, J. A., López-Sánchez, L. M., Herencia, C., Rodríguez-Ariza, A., Muñoz-Castañeda, J. R., & de la Mata, M. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007000700007 · Cited by 349
Mechanisms of drug-induced liver injury
Holt, M. P., & Ju, C. (2006) · The AAPS Journal · doi:10.1208/aapsj080106 · Cited by 328
Laville, N., Aı̈t-Aı̈ssa, S., Gomez, E., Casellas, C., & Porcher, J. M. (2004) · Toxicology · doi:10.1016/j.tox.2003.11.002 · Cited by 313
Mechanisms of Liver Injury. III. Oxidative stress in the pathogenesis of hepatitis C virus
Choi, J., & James Ou, J.-H. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00522.2005 · Cited by 310
Giacomini, K. M., Krauss, R. M., Roden, D. M., Eichelbaum, M., Hayden, M. R., & Nakamura, Y. (2007) · Nature · doi:10.1038/446975a · Cited by 276
Hepatotoxicity due to mitochondrial dysfunction
Pessayre, D., Mansouri, A., Haouzi, D., & Fromenty, B. (1999) · Cell Biology and Toxicology · doi:10.1023/a:1007649815992 · Cited by 274
Idiosyncratic Drug Reactions: Past, Present, and Future
Uetrecht, J. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700186p · Cited by 257
Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver
Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M., El May, M., Gharbi, N., Kamoun, A., & El-Fazaâ, S. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.11.044 · Cited by 250
Mitochondrial abnormalities—A link to idiosyncratic drug hepatotoxicity?
Boelsterli, U. A., & Lim, P. L. K. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.013 · Cited by 232
Xu, J. J., Diaz, D., & O’Brien, P. J. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.09.011 · Cited by 224
Self-citationUse of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport
Bi, Y.-A., Kazolias, D., & Duignan, D. B. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.009118 · Cited by 216 · cited 4×
“Recently, well-defined and characterized primary cultures of human hepatocytes were developed and demonstrated to maintain the differentiated functions of liver metabolism and transport (Bi et al., 2006; Davila et al., 2007; Gross-Steinmeyer et al., 2005; Hewitt et al., 2007; Hoffmaster et al., 2004; LeCluyse et al.,…”
BackgroundInfluentialDykens, J. A., Jamieson, J. D., Marroquin, L. D., Nadanaciva, S., Xu, J. J., Dunn, M. C., Smith, A. R., & Will, Y. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn056 · Cited by 195
Self-citationRecognizing Drug-Induced Liver Injury: Current Problems, Possible Solutions
Lee, W. M., & Senior, J. R. (2005) · Toxicologic Pathology · doi:10.1080/01926230590522356 · Cited by 190
Zimmerman, H. J. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70097-0 · Cited by 186
Li, A. P. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00051-0 · Cited by 181
Can Pharmacogenetics Help Rescue Drugs Withdrawn from the Market?
Shah, R. R. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.6.889 · Cited by 179
Thiazolidinediones and liver toxicity.
Scheen, A. J. (2001) · PubMed · Cited by 178
(1970) · Anesthesiology · doi:10.1097/00000542-197007000-00009 · Cited by 174
Idiosyncratic Liver Injury: Challenges and Approaches
Watkins, P. B. (2005) · Toxicologic Pathology · doi:10.1080/01926230590888306 · Cited by 166
Nonsteroidal Anti-Inflammatory Drug–Induced Hepatotoxicity
Aithal, G. P., & Day, C. P. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.004 · Cited by 164
Mechanisms of NSAID-Induced Hepatotoxicity: Focus on Nimesulide
Boelsterli, U. A. (2002) · Drug Safety · doi:10.2165/00002018-200225090-00003 · Cited by 159
Isolation and Culture of Primary Human Hepatocytes
LeCluyse, E. L., Alexandre, E., Hamilton, G. A., Viollon‐Abadie, C., Coon, D. J., Jolley, S. L., & Richert, L. (2004) · Humana Press eBooks · doi:10.1385/1-59259-838-2:207 · Cited by 157
Hoffmaster, K. A., Turncliff, R. Z., LeCluyse, E. L., Kim, R. B., Meier, P. J., & Brouwer, K. L. R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033018.97745.0d · Cited by 156
Kalgutkar, A. S. S., Vaz, A. D. N., Lame, M. E., Henne, K. R., Soglia, J. R., Zhao, S. X., Abramov, Y. A., Lombardo, F., Collin, C., Hendsch, Z. S., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001735 · Cited by 155
Chen, Q., Ngui, J. S., Doss, G. A., Wang, R. W., Cai, X., DiNinno, F. P., Blizzard, T. A., Hammond, M. L., Stearns, R. A., Evans, D. C., et al. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0200109 · Cited by 154
Dorne, J. L. C. M., Walton, K., & RENWICK, A. G. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.05.011 · Cited by 128
Kostrubsky, S. E., Strom, S. C., Kalgutkar, A. S. S., Kulkarni, S., Atherton, J., Mireles, R. J., Feng, B., Kubik, R., Hanson, J., Urda, E. R., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj095 · Cited by 121
Ross, D. B. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078032 · Cited by 115
Idiosyncratic Toxicity: A Convergence of Risk Factors
Ulrich, R. G. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.072905.160823 · Cited by 112
Hepatotoxicity Associated With the New Antidepressants
García‐Pando, A. C., del Pozo, J. G., Sanchez, A., Martín, A. V., de Castro, A. M. R., & Lucena, M. I. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0208 · Cited by 109
Potential for interaction of kava and St. John's wort with drugs
Singh, Y. N. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.05.014 · Cited by 108
Hepatotoxicity of antibiotics and antifungals
Thiim, M., & Friedman, L. S. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00021-7 · Cited by 87
Ito, K., Chiba, K., Horikawa, M., Ishigami, M., Mizuno, N., Aoki, J., Gotoh, Y., Iwatsubo, T., Kanamitsu, S.-I., Kato, M., et al. (2002) · AAPS PharmSci · doi:10.1208/ps040425 · Cited by 86
Zhao, S. X., Dalvie, D., Kelly, J. M., Soglia, J. R., Frederick, K. S., Smith, E. B., Obach, R. S., & Kalgutkar, A. S. S. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700132x · Cited by 83
Page, J. L., Johnson, M. C., Olsavsky, K. M., Strom, S. C., Zarbl, H., & Omiecinski, C. J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm034 · Cited by 83
Galisteo, M., Rissel, M., Sergent, O., Chevanne, M., Cillard, J., Guillouzo, A., & Lagadic‐Gossmann, D. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39052-4 · Cited by 79
Drug Hepatotoxicity from a Regulatory Perspective
Senior, J. R. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.002 · Cited by 73
TAVINTHARAN, S., Ong, C. N., Jeyaseelan, K., Sivakumar, M., Lim, S. K., & Sum, C. F. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.05.013 · Cited by 71
Nefazodone (Serzone) withdrawn because of hepatotoxicity.
Choi, S. (2003) · Europe PMC (PubMed Central) · Cited by 68
“Let There Be Bile”‐Understanding Hepatic Injury in Cholestasis
Sokol, R. J., Devereaux, M. W., Dahl, R., & Gumpricht, E. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000226384.71859.16 · Cited by 64
Castrillón, E. V. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5 · Cited by 56
Antioxidant effect of 2-hydroxy-4-methoxy benzoic acid on ethanol-induced hepatotoxicity in rats
Saravanan, N., Rajasankar, S., & Nalini, N. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.3.0015 · Cited by 48
Groß‐Steinmeyer, K., Stapleton, P. L., Tracy, J. H., Bammler, T. K., Lehman, T., Strom, S. C., & Eaton, D. L. (2005) · Xenobiotica · doi:10.1080/00498250500137427 · Cited by 42
Xu, J., Ma, M., & Purcell, W. M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00090-5 · Cited by 34
Self-citationRole of Mitochondria in Drug-Induced Cholestatic Injury
Kass, G. E. N., & Price, S. C. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.005 · Cited by 22
Tamoxifen cytotoxicity in hepatoblastoma cells stably transfected with human CYP3A4
Hołownia, A., & Braszko, J. J. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.027 · Cited by 17
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationAdvances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Gerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., & Atienzar, F. A. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-011-9208-4 · Cited by 698
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Organ-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Metadata
- Authors
- Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., & de Graaf, D.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-03
- Volume
- 105
- Issue
- 1
- Pages
- 97-105
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2132272495
- Cited by
- 492
- References
- 61
- FWCI
- 18.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.